CClinicalTrials.gg
RecruitingNCT05110248RADIUSUpdated May 20, 2026

Research and Development of Novel Quantitative Magnetic Resonance Imaging (MRI) Techniques in a Single Scan for Multiple Organ Application

An observational study in Multiple, sponsored by Perspectum. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-20.

Sponsored by Perspectum · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
600
Ages
18 Years and older
Sex
All
01

Study summary

Cross-sectional observational study to improve MRI data acquisition techniques by optimising MRI sequences for multiple organs and assessing the repeatability and reproducibility of multiparametric MRI, in healthy volunteers.

Read the detailed description

This will be a cross-sectional, observational study recruiting up to 600 participants designed at improving MRI data acquisition techniques by optimising MRI sequences and assessing different aspects of the repeatability and reproducibility of multiparametric MRI. Participants will be recruited from Perspectum's own volunteer database, PIC Sites, as well as through advertisements on social media platforms (e.g. Facebook, Instagram), Perspectum's website, as well as through charities.

Suitable participants will be invited to attend a screening visit, normally over the telephone, which will involve eConsent process, collection of participant's self-reported medical evaluation to assess eligibility according to the inclusion and exclusion criteria, and demographics. Visit 1 will consist of the collection of basic anthropometric measurements (e.g. height, weight, waist circumference), a medical history, a MRI scan and optional standard clinical reference assessments. Visit 2- 9 will be a repeat of visit 1 tests and an update on the medical history .

02

Conditions studied

  • Multiple
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Study participants will be adult volunteers aged 18 and over, without a contraindication to magnetic resonance imaging.

Inclusion criteria

  • Adults aged 18 years and older
  • Participant is willing and able to give informed consent for participation in the study
  • The participant has a level of English proficiency that allows them to communicate well with the investigator and could comply with study requirements.
  • The participant is willing and able to undergo MRI scan.

Exclusion criteria

Exclusion Criteria:

  • Any contraindication to magnetic resonance imaging (incl. pregnancy, nonremovable electronic implants including cochlear implants, infusion pumps, and pacemakers, shrapnel injury, severe claustrophobia, allergic reaction to contrast agents)
  • Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the study, or may influence the participant's ability to participate in the study
  • The participant may be excluded where body habitus is likely to make MRI or echocardiography/ultrasound uncomfortable or unlikely to yield analysable images, and BMI more than 40-45
04

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
600 participants (estimated)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Development of MRI sequences

    Development of sequences which will be used to collect good quality data on multiple organs across different MRI scanners and to ensure that desirable images are obtained within reasonable amount of time.

    Time frame: 7 years from study start

Secondary outcomes

  1. Sequence and parameter validation

    Validation of a list of sequences and parameter details

    Time frame: 7 years from study start

  2. Assessment of MRI metric repeatability

    Assessment of repeatability of the MRI metrics across 2 separate MRI acquisitions on the same scanner using statistical methods

    Time frame: 7 years from study start

  3. Assessment of MRI metric reproducibility

    Assessment of reproducibility of the MRI metrics in the same participants scanned on separate MRI scanners

    Time frame: 7 years from study start

  4. Assessment of participant comfort during scan

    Assessment of participant comfort during different MRI protocols with participant questionnaires.

    Time frame: 7 years from study start

  5. Assessment of Standard clinical reference assessment vs MRI

    Assessment of agreement between MRI derived measures and standard clinical reference assessments (ultrasound, echocardiography), in the same participants, including repeatability for both methods where applicable.

    Time frame: 7 years from study start

06

Study locations

1 of 1 sites recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT05110248
Lead sponsor
Perspectum
Responsible party
Sponsor
First posted
Nov 5, 2021
Start date
Nov 15, 2021
Primary completion
Mar 1, 2031 (estimated)
Completion
Apr 30, 2031 (estimated)
Last update
May 20, 2026

Study contacts

Soubera M Rymell, MSc
Contact
soubera.rymell@perspectum.com
00447313272482
Rob Suriano, PhD
Contact
rob.suriano@perspectum.com

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion